Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats
Authors:
Open Access
- 1 January 2015
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 21 (26) , 8061-8072
Abstract
AIM: To investigate the therapeutic effects of lutein against non-alcoholic fatty liver disease (NAFLD) and the related underlying mechanism. METHODS: After 9 d of acclimation to a constant temperature-controlled room (20 °C-22 °C) under 12 h light/dark cycles, male Sprague-Darley rats were randomly divided into two groups and fed a standard commercial diet (n = 8) or a high-fat diet (HFD) (n = 32) for 10 d. Animals receiving HFD were then randomly divided into 4 groups and administered with 0, 12.5, 25, or 50 mg/kg (body weight) per day of lutein for the next 45 d. At the end of the experiment, the perinephric and abdominal adipose tissues of the rats were isolated and weighed. Additionally, serum and liver lipid metabolic condition parameters were measured, and liver function and insulin resistance state indexes were assessed. Liver samples were collected and stained with hematoxylin eosin and Oil Red O, and the expression of the key factors related to insulin signaling and lipid metabolism in the liver were detected using Western blot and real-time polymerase chain reaction analyses. RESULTS: Our data showed that after being fed a high-fat diet for 10 d, the rats showed a significant gain in body weight, energy efficiency, and serum total cholesterol (TC) and triglyceride (TG) levels. Lutein supplementation induced fat loss in rats fed a high-fat diet, without influencing body weight or energy efficiency, and decreased serum TC and hepatic TC and TG levels. Moreover, lutein supplementation decreased hepatic levels of lipid accumulation and glutamic pyruvic transaminase content, and also improved insulin sensitivity. Lutein administration also increased the expression of key factors in hepatic insulin signaling, such as insulin receptor substrate-2, phosphatidylinositol 3-kinase, and glucose transporter-2 at the gene and protein levels. Furthermore, high-dose lutein increased the expression of peroxisome proliferators activated receptor-α and sirtuin 1, which are associated with lipid metabolism and insulin signaling. CONCLUSION: These results demonstrate that lutein has positive effects on NAFLD via the modulation of hepatic lipid accumulation and insulin resistance.Keywords
This publication has 37 references indexed in Scilit:
- Non Alcoholic Fatty Liver: Epidemiology and Natural HistoryReviews on Recent Clinical Trials, 2015
- Ameliorative Potential ofTamarindus indicaon High Fat Diet Induced Nonalcoholic Fatty Liver Disease in RatsThe Scientific World Journal, 2014
- Transitions of histopathologic criteria for diagnosis of nonalcoholic fatty liver disease during the last three decadesWorld Journal of Hepatology, 2014
- RETRACTED: Role of mammalian sirtuin 1 (SIRT1) in lipids metabolism and cell proliferation of goose primary hepatocytesMolecular and Cellular Endocrinology, 2014
- Hepatocyte-Specific Deletion of SIRT1 Alters Fatty Acid Metabolism and Results in Hepatic Steatosis and InflammationCell Metabolism, 2009
- Associations between body mass index and the prevalence of low micronutrient levels among US adults.2006
- Co-culture with fat cells induces cellular insulin resistance in primary hepatocytesBiochemical and Biophysical Research Communications, 2006
- Relation between insulin resistance and plasma concentrations of lipid hydroperoxides, carotenoids, and tocopherolsThe American Journal of Clinical Nutrition, 2000
- Insulin Receptor Substrate-2 Is Not Necessary for Insulin- and Exercise-stimulated Glucose Transport in Skeletal MuscleJournal of Biological Chemistry, 1999
- Diabetes Mellitus and Serum Carotenoids: Findings from the Third National Health and Nutrition Examination SurveyAmerican Journal of Epidemiology, 1999